We examine how various categories of healthcare spending waste may (or may not) align with the healthcare delivery and insurance realities in developing economies.

Although face-to-face interactions have always been the mainstay of the United States healthcare system, since the emergence of SARS-CoV-2 telehealth has been recognized as an equally useful method for healthcare delivery for some common services.

This paper focuses on studying prevalent methodologies and best practices in assessing the impact of new technology and claims costs and medical inflation from the perspective of medical insurers and is primarily aimed at non-US insurers.

Achieving fair provider payments is a key element for governments looking to expand universal healthcare programs.